JED JULARBAL: Open Payments
NPI 1780030320 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,590 in 86 payments from 21 companies in 2025. Trend: 2023 $1,998 · 2024 $1,602 · 2025 $1,590
Food & beverage: $1,590
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $442 |
| ABBVIE INC. | 17 | $252 |
| Axsome Therapeutics, Inc. | 10 | $165 |
| PFIZER INC. | 7 | $115 |
| Tris Pharma Inc | 4 | $73 |
| Medtronic, Inc. | 2 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| Astellas Pharma US Inc | 2 | $50 |
| Amgen Inc. | 3 | $49 |
| Dexcom, Inc. | 2 | $46 |
Products named: Wegovy, QULIPTA, VRAYLAR, Auvelity, NURTEC ODT, Symbravo, Rybelsus, Dyanavel XR.
Industry payments across TX — which companies pay providers there.
